HSBC Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Sell
33,100
-9,500
-22% -$9.63M 0.02% 639
2025
Q4
$45.8M Buy
42,600
+4,100
+11% +$3.92M 0.02% 516
2025
Q3
$29.3M Sell
38,500
-2,400
-6% -$1.79M 0.02% 608
2025
Q2
$31.8M Sell
40,900
-9,000
-18% -$6.99M 0.02% 580
2025
Q1
$41M Sell
49,900
-400
-0.8% -$333K 0.03% 525
2024
Q4
$38.8M Buy
50,300
+25,900
+106% +$21.4M 0.02% 544
2024
Q3
$21.4M Buy
24,400
+9,800
+67% +$8.81M 0.01% 701
2024
Q2
$13.3M Buy
14,600
+6,000
+70% +$4.8M 0.01% 787
2024
Q1
$6.69M Buy
8,600
+5,000
+139% +$3.56M ﹤0.01% 998
2023
Q4
$2.09M Sell
3,600
-2,500
-41% -$1.46M ﹤0.01% 1479
2023
Q3
$3.32M Sell
6,100
-500
-8% -$258K ﹤0.01% 1256
2023
Q2
$3.07M Buy
6,600
+6,400
+3,200% +$2.68M ﹤0.01% 1257
2023
Q1
$68.3K Sell
200
-19,800
-99% -$6.68M ﹤0.01% 2543
2022
Q4
$7.26M Hold
20,000
0.01% 1093
2022
Q3
$6.51M Hold
20,000
0.01% 1074
2022
Q2
$6.51M Buy
+20,000
New +$6M 0.01% 1092
2022
Q1
Sell
-9,200
Closed -$2.55M 3383
2021
Q4
$2.55M Sell
9,200
-10,300
-53% -$2.61M ﹤0.01% 1574
2021
Q3
$4.54M Buy
19,500
+400
+2% +$98.7K ﹤0.01% 1185
2021
Q2
$4.39M Buy
19,100
+9,000
+89% +$1.81M ﹤0.01% 1152
2021
Q1
$1.89M Buy
10,100
+1,300
+15% +$254K ﹤0.01% 1325
2020
Q4
$1.47M Sell
8,800
-7,800
-47% -$1.16M ﹤0.01% 1472
2020
Q3
$2.46M Buy
16,600
+4,400
+36% +$681K ﹤0.01% 1204
2020
Q2
$2M Buy
12,200
+900
+8% +$138K ﹤0.01% 1165
2020
Q1
$1.58M Sell
11,300
-19,700
-64% -$2.71M ﹤0.01% 1272
2019
Q4
$4.06M Sell
31,000
-44,600
-59% -$5.17M 0.01% 1191
2019
Q3
$8.45M Buy
75,600
+38,400
+103% +$4.28M 0.02% 933
2019
Q2
$4.12M Sell
37,200
-58,700
-61% -$6.91M 0.01% 1218
2019
Q1
$12.4M Sell
95,900
-10,200
-10% -$1.24M 0.02% 693
2018
Q4
$12.3M Buy
106,100
+67,400
+174% +$7.53M 0.02% 721
2018
Q3
$4.15M Buy
38,700
+14,900
+63% +$1.49M 0.01% 1199
2018
Q2
$2.03M Sell
23,800
-28,500
-54% -$2.34M ﹤0.01% 1495
2018
Q1
$4.05M Buy
+52,300
New +$4.21M 0.01% 1194
2017
Q4
Sell
-64,000
Closed -$5.47M 2244
2017
Q3
$5.47M Buy
64,000
+6,400
+11% +$525K 0.01% 999
2017
Q2
$4.74M Sell
57,600
-2,900
-5% -$237K 0.01% 994
2017
Q1
$5.09M Sell
60,500
-110,800
-65% -$8.87M 0.01% 923
2016
Q4
$12.6M Sell
171,300
-715,500
-81% -$53.3M 0.03% 635
2016
Q3
$71.2M Buy
886,800
+635,500
+253% +$50.9M 0.18% 119
2016
Q2
$19.8M Buy
251,300
+175,400
+231% +$13.2M 0.05% 423
2016
Q1
$5.47M Sell
75,900
-35,800
-32% -$2.71M 0.02% 856
2015
Q4
$9.41M Sell
111,700
-88,300
-44% -$7.33M 0.02% 711
2015
Q3
$16.7M Buy
+200,000
New +$16.9M 0.04% 448
2015
Q2
Sell
-36,000
Closed -$2.62M 2194
2015
Q1
$2.62M Sell
36,000
-160,100
-82% -$11.4M 0.01% 1110
2014
Q4
$13.5M Buy
196,100
+52,200
+36% +$3.52M 0.03% 569
2014
Q3
$9.33M Buy
143,900
+90,700
+170% +$5.74M 0.02% 680
2014
Q2
$3.31M Hold
53,200
0.01% 975
2014
Q1
$3.13M Sell
53,200
-240,000
-82% -$13.4M 0.01% 928
2013
Q4
$15M Hold
293,200
0.04% 496
2013
Q3
$14.8M Buy
+293,200
New +$15.3M 0.04% 473

Other funds holding LLY

HSBC Holdings's LLY Position: Q1 2026 in Review

HSBC Holdings reduced its Eli Lilly (LLY) stake by 6% in Q1 2026, selling an estimated $121M and leaving 1,865,688 shares worth $1.71B. The position accounts for 0.9% of the portfolio, ranked #14.

HSBC Holdings first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.13B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HSBC Holdings held 1,865,688 shares of Eli Lilly worth $1.71B as of Q1 2026.
  • HSBC Holdings sold 118,868 Eli Lilly shares in Q1 2026, an estimated $121M.
  • Eli Lilly made up 0.9% of HSBC Holdings's portfolio in Q1 2026, its #14 holding.
  • HSBC Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Eli Lilly position peaked at $2.13B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.